PAA
CTMX icon

Peregrine Asset Advisers’s CytomX Therapeutics CTMX Stock Holding History

Peregrine Asset Advisers’s Portfolio CTMX Stock Details CTMX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$22.7K Hold
10,000
– – 0.01% 168
2025
Q1 		$6.36K Hold
10,000
– – ﹤0.01% 161
2024
Q4 		$10.3K Hold
10,000
– – ﹤0.01% 167
2024
Q3 		$11.8K Buy
+10,000
New +$11.8K ﹤0.01% 181